What Makes Lifecore Biomedical (LFCR) a Beneficiary of the Trade Policies?
Greenhaven Road Capital, an investment management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Posts Tagged ‘NASDAQ:LFCR’
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q3 2025 Earnings Call Transcript
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q3 2025 Earnings Call Transcript April 3, 2025Lifecore Biomedical, Inc. misses on earnings expectations.
Greenhaven Road Capital’s Updates on Lifecore Biomedical (LFCR)
Greenhaven Road Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Micro Cap Stocks to Buy Now
Just as we overlook loose change, micro-cap stocks are often ignored for larger, more dominant enterprises.
Here are Laughing Water Capital’s Updates on Lifecore Biomedical (LFCR)
Laughing Water Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q2 2025 Earnings Call Transcript
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q2 2025 Earnings Call Transcript January 2, 2025Lifecore Biomedical, Inc. beats earnings expectations.
Here’s Why Arquitos Capital Management Largely Exited Lifecore (LFCR)
Arquitos Capital Management, an investment management firm, released its third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR)
Greenhaven Road Capital, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q1 2025 Earnings Call Transcript
Operator: Good morning, and thank you for joining Lifecore's Fiscal 2025 First Quarter Earnings Call. During the presentation, all participants will be in a listen-only mode.
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Lifecore Biomedical Q4 and Full Year 2024 Earnings Call. At this time all participants are in a listen-only mode.
Laughing Water Capital is Waiting for an Investor Update from Lifecore Biomedical (LFCR)
Laughing Water Capital, an investment management company, released its second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Cove Street Capital Sold its Holding in Lifecore Biomedical (LFCR)
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” second quarter 2024 investor letter.
Hidden Gems: Unveiling the 10 Stocks on Hedge Funds’ Radar
The US market sustained strong performance in the first quarter of 2024 as the S&P Index increased by 10.6%, continuing its momentum from the previous quarter.
Here’s Why Laughing Water Capital Invested in Lifecore Biomedical (LFCR)
Laughing Water Capital, an investment management company, released its first-quarter 2024 investor letter. A copy of the same can be downloaded here.
What Made White Falcon Hold Lifecore Biomedical (LFCR)?
White Falcon Capital Management, an investment fund manager, released its first quarter 2024 investor letter. A copy of the same can be downloaded here.
Do You Believe in the Upside Trajectory of Lifecore Biomedical (LFCR)?
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” first quarter 2024 investor letter.
Should You Hold Lifecore Biomedical (LFCR) for Long Term?
Laughing Water Capital, an investment management company, released its fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Here’s Why Cove Street Capital Reduced its Position in Lifecore Biomedical (LFCR)
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” fourth quarter 2023 investor letter.
Here’s Why Lifecore Biomedical (LFCR) Declined in Q3
Laughing Water Capital, an investment management company, released its third-quarter 2023 investor letter. A copy of the same can be downloaded here.
Here’s Why Cove Street Capital Sold Lifecore Biomedical (LFCR)
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” third quarter 2023 investor letter.
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q4 2023 Earnings Call Transcript
Operator: Good morning, and thank you for joining Lifecore's Fiscal 2023 Fourth Quarter Earnings Call. [Operator Instructions].
Do You Think Lifecore Biomedical (LFCR) Will Get Sold for a Healthy Premium?
Greenhaven Road Capital, an investment management company, released its second quarter 2023 investor letter. A copy of the same can be downloaded here.
Lifecore Biomedical (LFCR) Does Not Face Bankruptcy Risk Now
Laughing Water Capital, an investment management company, released its second-quarter 2023 investor letter. A copy of the same can be downloaded here.
Should You Invest in Lifecore Biomedical (LFCR)?
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” second quarter 2023 investor letter.
What Makes Lifecore Biomedical (LFCR) an Attractive Investment Opportunity?
Laughing Water Capital, an investment management company, released its first-quarter 2023 investor letter. A copy of the same can be downloaded here.
Here’s Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR)
Greenhaven Road Capital, an investment management company, released its first quarter 2023 investor letter. A copy of the same can be downloaded here.
Should You Hold Lifecore Biomedical (LFCR)?
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” first quarter 2023 investor letter.
Should You Invest in Lifecore Biomedical (LFCR)?
Laughing Water Capital, an investment management company, released its fourth-quarter 2022 investor letter. A copy of the same can be downloaded here.
Should You Hold Lifecore Biomedical (LFCR)?
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” fourth quarter 2022 investor letter.
